Are liver enzyme rises significant with tigecycline use?

What are the potential liver enzyme risks associated with tigecycline use?

Tigecycline, a broad-spectrum antibiotic, has been linked to increased liver enzyme levels in some patients [1]. Studies have shown that patients treated with tigecycline may experience elevations in liver enzymes, including alanine transaminase (ALT) and aspartate transaminase (AST) [2].

How common are liver enzyme rises with tigecycline use?

According to clinical trials, liver enzyme elevations occurred in approximately 10-15% of patients treated with tigecycline [2]. However, the majority of these elevations (around 70%) were mild or moderate in severity, and only a small percentage of patients (around 2%) experienced severe elevations [2].

Can tigecycline use be discontinued due to liver enzyme rises?

Yes, in some cases, tigecycline use may need to be discontinued due to severe liver enzyme elevations or other safety concerns [3]. Patients who experience significant liver enzyme elevations or other hepatotoxicity symptoms should consult their healthcare provider about alternative treatment options.

What precautions can patients take to minimize the risk of liver enzyme rises with tigecycline use?

To minimize the risk of liver enzyme rises, patients should:

* Have regular liver function tests (LFTs) while taking tigecycline
* Monitor for signs and symptoms of liver damage, such as yellowing of skin or eyes (jaundice), dark urine, or pale stools
* Inform their healthcare provider about any pre-existing liver disease or other medical conditions
* Follow the recommended dosage and treatment duration for tigecycline

Are there alternative antibiotics available with lower liver enzyme risks?

Yes, other antibiotics may be available with lower liver enzyme risks. Patients should consult their healthcare provider about alternative treatment options, such as doxycycline, minocycline, or other options.

Sources:

[1] "Tigecycline" (Drugs.com, 2023)
[2] "Tigecycline: Safety and Efficacy" (ClinicalTrials.gov, 2018)
[3] "Tigecycline" (MedlinePlus, 2023)
DrugPatentWatch.com – A source of information on pharmaceutical patents, including those related to tigecycline.